ArticleIET nanobiotechnology2023

A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual-responsive and CD206 targeting to improve the anti-tumour effect.

Changhai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.